Stock Information
Apellis Pharmaceuticals Inc (APLS)
Ticker Symbol: APLS
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $5,112.88 mil
Piotroski score: 5
PE Ratio: 232.9008
EPS (TTM): 0.1235
Revenue (TTM): $7.92 M
Dividend Yield: N/A%
ROE: 8.2%
Latest News
-
Biogen Taps Alloy Platform To Push Antisense Drug Pipeline Forward
Tue, Apr 7, 2026 8:54 AM
-
Apellis Stock Soars After Biogen Deal, Momentum Score Surges—Here's What Shareholders Get
Mon, Apr 6, 2026 6:40 AM
Key Financials
Financial data not available
